Home/Evia Bio/Jeffrey D. Allen
JD

Jeffrey D. Allen

Chairman & CEO

Evia Bio

Therapeutic Areas

Evia Bio Pipeline

DrugIndicationPhase
CellShield™ MSCCryopreservation of Mesenchymal Stromal CellsCommercial
CryoCustom DevelopmentCustom cell cryopreservation protocol developmentService
CryoGAP Risk AssessmentAudit and optimization of cryopreservation protocolsService